These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36388212)

  • 1. Epidemiology, clinical presentation, treatment, and outcome of neurosarcoidosis: A mono-centric retrospective study and literature review.
    Sambon P; Sellimi A; Kozyreff A; Gheysens O; Pothen L; Yildiz H; van Pesch V
    Front Neurol; 2022; 13():970168. PubMed ID: 36388212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presentations and outcomes of neurosarcoidosis: a study of 54 cases.
    Pawate S; Moses H; Sriram S
    QJM; 2009 Jul; 102(7):449-60. PubMed ID: 19383611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features, treatment and outcome in neurosarcoidosis: systematic review and meta-analysis.
    Fritz D; van de Beek D; Brouwer MC
    BMC Neurol; 2016 Nov; 16(1):220. PubMed ID: 27846819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurosarcoidosis].
    Briner VA; Müller A; Gebbers JO
    Schweiz Med Wochenschr; 1998 May; 128(21):799-810. PubMed ID: 9642746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes of refractory neurosarcoidosis treated with infliximab.
    Cohen Aubart F; Bouvry D; Galanaud D; Dehais C; Mathey G; Psimaras D; Haroche J; Pottier C; Hie M; Mathian A; Devilliers H; Nunes H; Valeyre D; Amoura Z
    J Neurol; 2017 May; 264(5):891-897. PubMed ID: 28260120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcoidosis and the Nervous System.
    Pawate S
    Continuum (Minneap Minn); 2020 Jun; 26(3):695-715. PubMed ID: 32487903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and outcome of neurosarcoidosis-associated myelitis: A retrospective cohort study and review of the literature.
    Nolte JYC; Ten Dam L; van de Beek D; Brouwer MC
    Eur J Neurol; 2022 Jun; 29(6):1763-1770. PubMed ID: 35189010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated CNS Sarcoidosis Versus Systemic Sarcoidosis With CNS Involvement: A Same Disease?
    Courtin E; Ouallet JC; Lazaro E; Martin-Negrier ML; Cohen-Aubart F; Duffau P
    Neurohospitalist; 2022 Apr; 12(2):290-294. PubMed ID: 35419160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurosarcoidosis: clinical presentations and changing treatment patterns in an Irish Caucasian population.
    O'Connell K; Williams L; Jones J; McCabe DJH; Murphy D; Killeen R; Tubridy N; O'Riordan S; McGuigan C
    Ir J Med Sci; 2017 Aug; 186(3):759-766. PubMed ID: 28101825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurosarcoidosis in a Tertiary Referral Center: A Cross-Sectional Cohort Study.
    Leonhard SE; Fritz D; Eftimov F; van der Kooi AJ; van de Beek D; Brouwer MC
    Medicine (Baltimore); 2016 Apr; 95(14):e3277. PubMed ID: 27057889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinguishing neurosarcoidosis from multiple sclerosis based on CSF analysis: A retrospective study.
    Arun T; Pattison L; Palace J
    Neurology; 2020 Jun; 94(24):e2545-e2554. PubMed ID: 32354749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurosarcoidosis of the Cauda Equina: Clinical Course, Radiographic and Electrodiagnostic Findings, Response to Treatment, and Outcomes.
    Bou GA; Garcia-Santibanez R; Castilho AJ; Hutto SK
    Neurol Neuroimmunol Neuroinflamm; 2022 Jul; 9(4):. PubMed ID: 35487693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of immunotherapies and clinical outcomes in neurosarcoidosis: a retrospective cohort study.
    Arun T; Palace J
    J Neurol; 2021 Jul; 268(7):2466-2472. PubMed ID: 33515298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Protean Neuropsychiatric and Vestibuloauditory Manifestations of Neurosarcoidosis.
    Greene JJ; Naumann IC; Poulik JM; Nella KT; Weberling L; Harris JP; Matsuoka AJ
    Audiol Neurootol; 2017; 22(4-5):205-217. PubMed ID: 29166635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurosarcoidosis.
    Lacomis D
    Curr Neuropharmacol; 2011 Sep; 9(3):429-36. PubMed ID: 22379457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and Long-Term Outcome of Neurosarcoidosis: A Population-Based Study from 1976-2013.
    Ungprasert P; Crowson CS; Matteson EL
    Neuroepidemiology; 2017; 48(3-4):87-94. PubMed ID: 28601860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-TNF-α therapy in the management of severe neurosarcoidosis: a report of five cases from a single centre and literature review.
    Riancho-Zarrabeitia L; Delgado-Alvarado M; Riancho J; Oterino A; Sedano MJ; Rueda-Gotor J; Pérez-Martín I; González-Vela MC; Berciano J; González-Gay MA; Blanco R
    Clin Exp Rheumatol; 2014; 32(2):275-84. PubMed ID: 24321604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of neurosarcoidosis: A comparative study of methotrexate and mycophenolate mofetil.
    Bitoun S; Bouvry D; Borie R; Mahevas M; Sacre K; Haroche J; Psimaras D; Pottier C; Mathian A; Hie M; Boutin DL; Papo T; Godeau B; Valeyre D; Nunes H; Amoura Z; Cohen Aubart F
    Neurology; 2016 Dec; 87(24):2517-2521. PubMed ID: 27856779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurosarcoidosis according to Zajicek and Scolding criteria: 15 probable and definite cases, their treatment and outcomes.
    Cação G; Branco A; Meireles M; Alves JE; Mateus A; Silva AM; Santos E
    J Neurol Sci; 2017 Aug; 379():84-88. PubMed ID: 28716286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurosarcoidosis: Longitudinal experience in a single-center, academic healthcare system.
    Lord J; Paz Soldan MM; Galli J; Salzman KL; Kresser J; Bacharach R; DeWitt LD; Klein J; Rose J; Greenlee J; Clardy SL
    Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32404428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.